Monday, February 01, 2021 12:31:40 AM
I will correct you.
I hink some of those here have confused you.
MF never stated he would share data news at end of year.
That is over enthusiastic iHub boarders who are projecting their wishes upon other’s expectations.
He did state that they would hit initial data point by end of 2020.
In fact if you look at what MF says, he has been vague.
Why?
> they’re small, they have to play by the rules
> they are in constant contact with FDA,
> they’re protecting their patent application
But, you have to look beyond what Revive says.
He did acknowledge that 210 mark was enrolled by years end.
He just got more funding.
He hired a Thiol Donor Researcher.
Pharm-Olam has expanded sites.
The 1000 patient trial mark should be hit by February 1st, so I imagine data would come prior to the end of February. But we’ll see, because like everyone on here, it’s a best guess.
In fact right now, Only Pharm-Olam personnel probably know any results.
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM